Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...
In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...
Stream NBC 5 for free, 24/7, wherever you are. On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck.
Science, laboratory and people on computer for medical analysis, research and medicine development AI drug design and development company Isomorphic Labs announced on Monday that it raised $600 ...
The company will build off of breakthroughs in protein prediction from DeepMind and inches Big Tech one step further into the healthcare industry. reading time 2 minutes Alphabet has spun off a new ...
Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer. By Michael J. de la Merced Reporting from London Over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback